Market Overview:

The Japan dietary supplements market size was valued at USD 2.93 billion in 2023and is expected to be worth USD 3.09 billion in 2024. The market is projected to reach USD 5.20 billion in 2032, recording a CAGR of 6.72% during the forecast period.

Dietary supplements refer to products that contain vitamins, minerals, herbs, and amino acids to help consumers fulfill their daily nutritional needs. They can be consumed in several forms, such as pills, powders, tablets, and drinks to help them tackle a wide range of nutritional deficiencies. Increasing awareness regarding the importance of having optimum mental and physical health will boost the product’s sales.

LIST OF KEY COMPANIES PROFILED IN THE REPORT

• Otsuka Pharmaceutical Co., Ltd. (Japan)
• FANCL Corporation (Japan)
• Ajinomoto Co., Inc. (Japan)
• Meiji Holdings Co., Ltd. (Japan)
• Groupe Danone (Japan)
• Nestle Health Science (Japan)
• House Foods Group Inc., (Japan)
• ORIHIRO Co., Ltd. (Japan)
• Fine Japan (Japan)
• Kowa Company, Ltd (Japan)

Segmentation:

Increasing Incidence of Vitamin Deficiencies in Pregnant Women Fuels Demand for Vitamin Supplements

Based on type, the market is segmented into vitamins, minerals, enzymes, fatty acids, proteins, and others. The vitamin supplements segment is dominating the market as an increasing number of pregnant women across Japan are suffering from various vitamin deficiencies, such as vitamins B12 and D, folate, magnesium, and calcium.

Decreased Production Complications and Ability to Hide Bad Odor Bolsters Sales of Tablet-based Dietary Supplements

Based on form, the market is divided into tablets, capsules, liquid, powder, and others. The tablets segment is dominating the Japan dietary supplements market share as tablet-based nutraceuticals do not cause major production challenges and can easily hide bad odor and taste.

Increasing Focus On Health & Wellbeing Among Elderly Bolsters Consumption of General Health Dietary Supplements